Cardinal Health

Preço: 223.85

Empresa e modelo de negócios

Cardinal Health is a global healthcare services and products company. It operates in two main segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceuticals, while the Medical segment provides medical and surgical products. Major revenue sources include pharmaceutical distribution, medical product sales, and supply chain services.

Perfil de investimento

The investment profile of Cardinal Health is more aligned with balanced investors, given its stable revenue growth and moderate dividend yield. The company demonstrates potential for steady returns while maintaining a manageable risk level. This profile may appeal to those seeking a combination of growth and income.

Site oficial

Métricas fundamentais (experimental)

EPS (TTM) — lucro por ação dos últimos 12 meses, $: 6.56 OK
Receita QoQ — crescimento da receita trimestre contra trimestre: -6.9% ↓
Surpresa de EPS: 12.4% melhor que o esperado
Volatilidade 20d: 1.4% estável
Dividend yield: 1.2% moderado última data ex-dividendo: 2026-04-01

Dados FMP / FinFeed atualizados: 2026-06-13

Rec.: Comprar Potencial: 68 Risco: 41 Atualizado: 2026-06-13 02:54

Como a recomendação funciona

Por que a IA pensa assim:

Positive momentum, but revenue decline raises concerns.

Acompanhar no portfólio

Gráfico de preço

Recomendação da IA Previsão do analista Evento de calendário Sinal positivo Sinal negativo Neutro / atualização Manter / informativo B My buy S My sell

Mudanças na recomendação da IA

Data	Antes	Depois	Motivo
2026-06-05 02:33	Manter	Comprar	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-05-24 02:34	Comprar	Manter	Mixed performance; cautious outlook amid market pressures.
2026-05-16 02:39	Manter	Comprar	Mixed momentum; fundamentals show moderate strength.
2026-05-08 15:10	—	Manter	Weak momentum and high risk overshadow fundamentals.
2026-05-08 05:35	Manter	Manter	Компания показывает отрицательную динамику цен на акции за последние месяцы, однако имеет стабильный EPS и небольшой рост выручки. Рекомендуется удерживать акции до прояснения ситуации на рынке.
2026-04-25 02:54	Comprar	Manter	Компания показывает умеренный рост выручки и положительный сюрприз по EPS, однако недавние падения цены акций и негативные тренды на коротких сроках вызывают опасения.
2026-01-30 14:35	Manter	Comprar	Компания показывает сильный рост за последние 120 дней, что свидетельствует о положительной динамике. Умеренный риск связан с отсутствием данных по EPS и доходам, но общий тренд выглядит многообещающе.
2026-01-29 08:50	Comprar	Manter	Компания показывает стабильный рост за последние 120 дней, однако отсутствие данных по EPS и доходам вызывает некоторые опасения. Рекомендуется удерживать акции до получения более ясной финансовой информации.

Previsões de analistas

Data	Analista	Action	Alvo	Preço na época
2026-05-01 12:45	Robert W. Baird	Preço-alvo reduzido	257 → 248	195.08
2026-04-08 13:11	Evercore ISI	Preço-alvo reduzido	260 → 240	215.13
2026-03-09 17:22	Leerink Partners	Atualizar	— → 275	222.28
2026-02-24 10:22	Barclays	Preço-alvo elevado	243 → 258	224.82
2026-02-10 11:36	Wells Fargo	Preço-alvo elevado	237 → 256	225.76
2026-02-06 15:43	Morgan Stanley	Preço-alvo elevado	245 → 255	229.63
2026-02-06 14:43	Robert W. Baird	Preço-alvo elevado	250 → 252	228.7841
2026-02-06 13:14	UBS	Preço-alvo elevado	250 → 260	228.63
2026-02-06 12:33	Mizuho Securities	Preço-alvo elevado	222 → 235	227.18
2026-02-05 19:21	Evercore ISI	Preço-alvo elevado	— → 260	227.18
2026-01-29 12:20	Morgan Stanley	Preço-alvo elevado	224 → 245	210.39

Cramer Highlights Buying Opportunity in AI Stocks Amid Market Cooling

06/05/2026, 10:33 AM economy review ai tech CrowdStrike Cardinal Health Intel Johnson & Johnson Apple Broadcom Eli Lilly

The recent decline in stock prices, particularly in the tech sector, presents a potential buying opportunity for investors, especially in chip stocks and AI-related companies, according to Jim Cramer.